期刊文献+

奥美拉唑国内外价格比较分析 被引量:1

Comparative analysis of Omeprazole price at home and abroad
暂未订购
导出
摘要 通过对比奥美拉唑在我国11个省的中标价格、国产药与进口药价格,以及与国外价格的对比,发现我国奥美拉唑价格的现状:福建省的价格低于其它各省,进口药价格明显高于国产药,我国的价格远高于国外价格。对此提出,提高药品研发创新能力、推广福建的有益经验、参照国际参考价进行定价、加快推进国产仿制药的推广和使用等建议。 This paper analyzed the current situation of Omeprazole price by comparing the bid price of Omeprazole in 11 provinces in China,the price of domestic and imported drug and the price in foreign countries. The results show that the price of Omeprazole in Fujian Province is lower than that in other provinces, the price of imported drug is obviously higher than that of domestic drug, and Omeprazole price in our country is much higher than that in foreign countries. Some suggestions are put forward, including improving the innovation ability of drug research and development, popularizing the beneficial experience from Fujian province, pricing according to international reference price, and speeding up the promotion and use of domestic generic drugs.
作者 胡宗铃 傅鸿鹏 HU Zong-ling;FU Hong-pen(School of health management and education,Capital Medical University Beijing 100069)
出处 《卫生经济研究》 北大核心 2018年第7期15-18,共4页
关键词 奥美拉唑 中标价格 国际参考价格 中位价格比值法 Omeprazole Bid price International reference price Median price ratio method
  • 相关文献

参考文献7

二级参考文献24

  • 1国家统计局.国家数据[EB/OL].[2012-11-18].http://www.stats.gov.cn.
  • 2World Health Organization,Health Action International.Measuring medicine prices,availability,affordability and price components[EB/OL].(2008)[2014-12-12].http://www.who.int/medicines/areas/access/medicines_prices08/en/.
  • 3Cameron A,Ewen M,Ross-Degnan D,et al.Medicine prices,availability,and affordability in36developing and middle-income countries:a secondary analysis[J].Lancet,2009,373(9 659):240.
  • 4The World Bank.ICP2011:international comparison program[EB/OL].(2011)[2014-11-28].http://siteresources.worldbank.org/ICPEXT/Resources/ICP_2011.html2014.
  • 5Mendis S,Fukino K,Cameron A,et al.The availability and affordability of selected essential medicines for chronic diseases in six low-and middle-income countries[J].Bull World Health Organ,2007,85(4):279.
  • 6中国共产党第十八届中央委员会第五次全体会议公报[EB/OL].http://news.xinhuanet.com/fortune/2015—10/29/c-1116983078.htm.
  • 7WHO. WHO Model List of Essential Medicines [EB/OL]. http://www.who.int/selection_medicines/commit tees/expert/20/EML_2015_FINAL_amended_AUG2015. pdf?.ua=l.
  • 8WHO. International Drug Price Indicator Guide [EB/OL]. http://erc.msh.org/mainpage.cfm?file= 1.0.htm&m odule=Dmp&language=English.
  • 9Pharmaceutical Benefits Scheme. Schedule of Pharmaceutical Benefits [EB/OL]. http://www.pbs.gov. au/pbs/home.
  • 10Pharmaceutical Management Agency.New Zealand Pharmaceutical Schedule Section H for Hospital Pharma- ceuticals. Pharmaceutical Management Agency: New Zealand,2015.

共引文献19

同被引文献9

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部